JPH11222440A5 - - Google Patents
Info
- Publication number
- JPH11222440A5 JPH11222440A5 JP1998021809A JP2180998A JPH11222440A5 JP H11222440 A5 JPH11222440 A5 JP H11222440A5 JP 1998021809 A JP1998021809 A JP 1998021809A JP 2180998 A JP2180998 A JP 2180998A JP H11222440 A5 JPH11222440 A5 JP H11222440A5
- Authority
- JP
- Japan
- Prior art keywords
- pth
- leukopenia
- cells
- administration
- bone marrow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP02180998A JP4414494B2 (ja) | 1998-02-03 | 1998-02-03 | 白血球減少症の予防剤および治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP02180998A JP4414494B2 (ja) | 1998-02-03 | 1998-02-03 | 白血球減少症の予防剤および治療剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11222440A JPH11222440A (ja) | 1999-08-17 |
| JPH11222440A5 true JPH11222440A5 (cs) | 2005-07-07 |
| JP4414494B2 JP4414494B2 (ja) | 2010-02-10 |
Family
ID=12065393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP02180998A Expired - Fee Related JP4414494B2 (ja) | 1998-02-03 | 1998-02-03 | 白血球減少症の予防剤および治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4414494B2 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9904177A3 (en) | 1996-09-26 | 2001-10-29 | Chugai Pharmaceutical Co Ltd | Antibody against human parathormone related peptides |
| ES2285769T3 (es) | 1997-05-15 | 2007-11-16 | Chugai Seiyaku Kabushiki Kaisha | Remedio para la caquexia. |
| TWI255718B (en) | 1999-07-02 | 2006-06-01 | Chugai Pharmaceutical Co Ltd | Ameliorative agent for low vasopressin concentration |
| EP1197225A4 (en) * | 1999-07-02 | 2006-02-22 | Chugai Pharmaceutical Co Ltd | AGENTS FOR DISEASES CAUSED BY PTH OR PTHrH |
| JP4846169B2 (ja) | 2000-04-28 | 2011-12-28 | 中外製薬株式会社 | 細胞増殖抑制剤 |
-
1998
- 1998-02-03 JP JP02180998A patent/JP4414494B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2128056C1 (ru) | Способы и препараты для лечения заболеваний интерфероном, характеризующиеся сниженными побочными эффектами | |
| JP2914393B2 (ja) | ヒトサイトカイン、インターロイキン―９ | |
| ES2380009T3 (es) | Métodos para movilizar las células madre/progenitoras | |
| JP4416839B2 (ja) | 二次性免疫不全症の治療法 | |
| US6719969B1 (en) | Treatment of liver disease and injury with CXC chemokines | |
| JPH10510147A (ja) | 二次性免疫不全症の治療用薬剤の製造方法 | |
| RU2351357C2 (ru) | Фармацевтическая композиция, используемая для мобилизации стволовых клеток | |
| JP2846629B2 (ja) | 組換えコロニー刺激因子−１を含んで成る医薬組成物 | |
| US5104653A (en) | Use of human interferon-beta for stimulation of erythropoiesis | |
| JP3496937B2 (ja) | コンセンサスヒトインターフェロンを含有する細胞増殖障害治療用の医用組成物 | |
| JPH06510769A (ja) | 低血圧症と関連疾患の治療のためのアミノ酸非経口製剤 | |
| JPH11222440A5 (cs) | ||
| JP4414494B2 (ja) | 白血球減少症の予防剤および治療剤 | |
| JPH11512747A (ja) | 造血幹細胞の動員方法 | |
| Gabrilove et al. | Granulocyte colony-stimulating factor: preclinical and clinical studies | |
| WO2006132236A1 (ja) | 白血球及び／又は造血幹・前駆細胞動員剤 | |
| JPH04506818A (ja) | 造血細胞の成熟 | |
| Parker et al. | Inhibitors of haemopoiesis and their potential clinical relevance | |
| JP2597953B2 (ja) | 制癌剤 | |
| US20030099637A1 (en) | Remedies for interstitial pneumonia , method of constructing animal model of this disease, and screening method with the use of the same | |
| WO2004016258A1 (en) | Therapeutical use of guanylhydrazones for treating diseases associated with dendritic cell maturation | |
| JPH04218365A (ja) | 動物細胞増殖促進剤及び無血清培地 | |
| JP2002510641A (ja) | 神経退化疾患治療用短ペプチド | |
| Hoyos-Bachiloglu et al. | Precision medicine as treatment for primary immunodeficiency and immune dysregulation | |
| WO2001010899A2 (en) | Treatment of liver disease and injury with cxc chemokines |